BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22197716)

  • 1. Luciferase inhibition by a novel naphthoquinone.
    Bedford R; LePage D; Hoffmann R; Kennedy S; Gutschenritter T; Bull L; Sujijantarat N; DiCesare JC; Sheaff RJ
    J Photochem Photobiol B; 2012 Feb; 107():55-64. PubMed ID: 22197716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase I/II inhibition by a novel naphthoquinone containing a modified anthracycline ring system.
    Kennedy S; DiCesare JC; Sheaff RJ
    Biochem Biophys Res Commun; 2011 Apr; 408(1):94-8. PubMed ID: 21458415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase I inactivation by a novel thiol reactive naphthoquinone.
    Kennedy S; Dicesare JC; Sheaff RJ
    Biochem Biophys Res Commun; 2011 Jun; 410(1):152-8. PubMed ID: 21651895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cell death by a novel naphthoquinone containing a modified anthracycline ring system.
    Carvajal D; Kennedy S; Boustani A; Lazar M; Nguyen S; DiCesare JC; Sheaff RJ
    Chem Biol Drug Des; 2011 Nov; 78(5):764-77. PubMed ID: 21838760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporter enzyme inhibitor study to aid assembly of orthogonal reporter gene assays.
    Ho PI; Yue K; Pandey P; Breault L; Harbinski F; McBride AJ; Webb B; Narahari J; Karassina N; Wood KV; Hill A; Auld DS
    ACS Chem Biol; 2013 May; 8(5):1009-17. PubMed ID: 23485150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors.
    Liu Y; Fang J; Cai H; Xiao F; Ding K; Hu Y
    Bioorg Med Chem; 2012 Sep; 20(18):5473-82. PubMed ID: 22898255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of inhibition of firefly luciferase by dehydroluciferyl-coenzyme A, dehydroluciferin and L-luciferin.
    da Silva LP; da Silva JC
    Photochem Photobiol Sci; 2011 Jun; 10(6):1039-45. PubMed ID: 21409209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear factor κB inhibitor (E)-2-fluoro-4'-methoxystilbene inhibits firefly luciferase.
    Braeuning A; Vetter S
    Biosci Rep; 2012 Dec; 32(6):531-7. PubMed ID: 22789175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of inhibition of firefly luciferase by oxyluciferin and dehydroluciferyl-adenylate.
    Ribeiro C; Esteves da Silva JC
    Photochem Photobiol Sci; 2008 Sep; 7(9):1085-90. PubMed ID: 18754056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protocol for combined Photinus and Renilla luciferase quantification compatible with protein assays.
    Hampf M; Gossen M
    Anal Biochem; 2006 Sep; 356(1):94-9. PubMed ID: 16750160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects associated with use of modified Photinus pyralis and Renilla reniformis luciferase vectors in dual reporter assays and implications for analysis of ISGs.
    Ghazawi I; Cutler SJ; Low P; Mellick AS; Ralph SJ
    J Interferon Cytokine Res; 2005 Feb; 25(2):92-102. PubMed ID: 15695930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Firefly luciferase inhibition.
    Leitão JM; Esteves da Silva JC
    J Photochem Photobiol B; 2010 Oct; 101(1):1-8. PubMed ID: 20655239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of an N-acyl sulfamate analog of luciferyl-AMP: a stable and potent inhibitor of firefly luciferase.
    Branchini BR; Murtiashaw MH; Carmody JN; Mygatt EE; Southworth TL
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3860-4. PubMed ID: 15990297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis evidence that the partial reactions of firefly bioluminescence are catalyzed by different conformations of the luciferase C-terminal domain.
    Branchini BR; Southworth TL; Murtiashaw MH; Wilkinson SR; Khattak NF; Rosenberg JC; Zimmer M
    Biochemistry; 2005 Feb; 44(5):1385-93. PubMed ID: 15683224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between stability and bioluminescence color of firefly luciferase.
    Maghami P; Ranjbar B; Hosseinkhani S; Ghasemi A; Moradi A; Gill P
    Photochem Photobiol Sci; 2010 Mar; 9(3):376-83. PubMed ID: 20221465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of thermostability and activity of firefly luciferase through [TMG][Ac] ionic liquid mediator.
    Ebrahimi M; Hosseinkhani S; Heydari A; Khavari-Nejad RA; Akbari J
    Appl Biochem Biotechnol; 2012 Oct; 168(3):604-15. PubMed ID: 22810202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferase.
    Heitman LH; van Veldhoven JP; Zweemer AM; Ye K; Brussee J; IJzerman AP
    J Med Chem; 2008 Aug; 51(15):4724-9. PubMed ID: 18646744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the spectral difference in luciferase bioluminescence.
    Nakatsu T; Ichiyama S; Hiratake J; Saldanha A; Kobashi N; Sakata K; Kato H
    Nature; 2006 Mar; 440(7082):372-6. PubMed ID: 16541080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of disulfide bridge as an alternative mechanism for color shift in firefly luciferase and development of secreted luciferase.
    Nazari M; Hosseinkhani S
    Photochem Photobiol Sci; 2011 Jul; 10(7):1203-15. PubMed ID: 21494742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quenching the firefly bioluminescence by various ions.
    Zhang H; Bai H; Jiang T; Ma Z; Cheng Y; Zhou Y; Du L; Li M
    Photochem Photobiol Sci; 2016 Feb; 15(2):244-9. PubMed ID: 26789132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.